Human study of iPS cells advances toward approval in Japan

A panel of Japan's Health Ministry has approved a clinical study involving induced pluripotent stem cells. The study is a type of pretrial clinical research that will focus on the use of iPS cells in treating eye disease. The decision could pave the way for final approval by the health minister.

View Full Article in:

Japan Times, The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR